Ashkan Mowla, MD
Neurology · Los Angeles, CANPI 1659607190
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Johnson & Johnson at 26.2% of the total. Reporting peaked in 2022 at $60,685 and has fallen 93.6% since, to $3,888 in 2025. Among neurology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 440 payments — averaging $374.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$43K
- AstraZeneca$35K
- Medtronic$26K
- Medical Device Business Services, Inc.$14K
- Depuy Synthes Products, Inc.$11K
- Stryker$10K
- plus $27K from 15 others
Across 9 payments — averaging $2754.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$17K
- Janssen Research & Development, LLC$5K
- Ipsen Innovation$3K
What the payments were for
- Consulting fees$34,97821%
- Speaking & faculty fees$81,33549%
- Travel & lodging$26,19616%
- Food & beverage$22,31014%
- Gifts$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 99 | $43,252 |
| AstraZeneca(2 entities) | 47 | $34,743 |
| Medtronic(3 entities) | 86 | $25,623 |
| Medical Device Business Services, Inc. | 51 | $14,166 |
| Depuy Synthes Products, Inc. | 4 | $10,662 |
| Stryker | 66 | $9,624 |
| Ischemaview, Inc. | 3 | $9,488 |
| Portola Pharmaceuticals, LLC | 10 | $4,611 |
| Abbott | 16 | $3,040 |
| Penumbra, Inc. | 18 | $2,593 |
| Balt USA, LLC | 7 | $2,247 |
| Ipsen Innovation | 5 | $1,850 |
| Rapid Medical Ltd | 4 | $817 |
| Imperative Care, Inc | 12 | $792 |
| Janssen Scientific Affairs, LLC | 5 | $331 |
| Phenox Inc. | 2 | $330 |
| Route 92 Medical, Inc. | 1 | $245 |
| Philips North America LLC | 1 | $133 |
| Viz.ai, Inc. | 1 | $125 |
| Biosense Webster, Inc. | 1 | $85 |
| Microvention, Inc. | 1 | $69 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$38,524
- XARELTO$38,121
- SPOTLIGHT$10,528
- TRUFILL$10,316
- Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$5,545
- PULSERIDER$4,290
- EMBOTRAP II Revascularization Device$4,194
- TREVO$3,281
- Emboshield NAV6 system$2,353
- TARGET$1,705
- Penumbra System$1,425
- RIST$1,392
- Pipeline$1,062
- Reveal LINQ$980
- Embotrap$952
- SPINEJACK$839
- COMANECI 17$730
- TIGERTRIEVER 17 REVASCULARIZATION DEVICE$730
- NEUROFORM EZ$680
- LINQ II$583
How this compares
$164,826 in reported general payments places this provider in the 95th percentile of 1,996 neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Los Angeles
- Perry ShiehLos Angeles$2.4M
- David LiebeskindLos Angeles$1.9M
- John SternLos Angeles$999K
- Jeffrey CummingsLos Angeles$918K
- Alan RapoportLos Angeles$808K
- Alon AvidanLos Angeles$505K
- Mark LewLos Angeles$450K
- Dawn EliashivLos Angeles$364K
- Richard LewisLos Angeles$309K
- Margaret BurnettLos Angeles$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.